Check out our most popular compounded medications! Get Started
Imiquimod 0.5% Vaginal Gel is a gel-like semisolid formulation, dispensed in a tube for easy and controlled application in the vaginal area. It is specifically designed to deliver medication for the treatment of conditions such as Vulvar Intraepithelial Neoplasia, Genital Warts, Actinic Keratosis, Basal Cell Carcinoma, and Bowen's Disease. This formulation also provides lubrication and therapeutic effects for various gynecological purposes.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Imiquimod 0.5% Vaginal Gel is a specially compounded formulation designed for topical application in the vaginal area. This gel-like semisolid medication is dispensed in a tube for easy and controlled application. It is primarily used for the treatment of various conditions such as genital warts, actinic keratosis, and superficial basal cell carcinoma.
The active ingredient, Imiquimod, works by stimulating the body's own immune system to combat the infection or cancer. This makes it a appropriate treatment option for these conditions. The gel is applied directly to the affected area, ensuring targeted treatment and minimizing systemic side effects.
It is crucial to use Imiquimod 0.5% Vaginal Gel as directed by a healthcare provider. The dosage and duration of treatment may vary depending on the condition being treated and the patient's overall health status. It is also important to note that this medication should not be used by pregnant women or those who are breastfeeding, due to potential risks to the baby.
At Bayview Pharmacy, our team of compounding pharmacists is well-versed in the preparation and use of Imiquimod 0.5% Vaginal Gel. We are committed to providing you with the highest quality of care and guidance. If you have any questions or concerns about this medication, or if you need further information on how to use it, please do not hesitate to contact us.
Imiquimod 0.5% Vaginal Gel is a specialized formulation designed for controlled application in the vaginal area. This medication may interact with other drugs, including those taken orally or applied topically. It is crucial for patients to inform their healthcare provider of all medications they are currently taking, including over-the-counter drugs, vitamins, and herbal supplements. This is to ensure that there are no adverse interactions between the medications.
Patients should also disclose any allergies or medical conditions they may have to their healthcare provider. Imiquimod 0.5% Vaginal Gel may interact with certain medications used to treat various conditions such as HIV, tuberculosis, and other infections. It may also interact with certain cancer treatments, including chemotherapy drugs.
Imiquimod 0.5% Vaginal Gel is not recommended for use in pregnant or breastfeeding women. It may also interact with certain topical medications used to treat skin conditions such as acne, psoriasis, and others. Patients should refrain from using Imiquimod 0.5% Vaginal Gel if they are taking any of these medications.
If you have any questions or concerns about the interactions of Imiquimod 0.5% Vaginal Gel with other medications, it is recommended to consult with your healthcare provider or pharmacist for further information and guidance.
Imiquimod 0.5% Vaginal Gel is a specially formulated topical medication designed for the treatment of genital warts, vulvar intraepithelial neoplasia (VIN), and external genital lesions caused by the human papillomavirus (HPV). This unique gel works by stimulating the body's own immune system to combat the virus, providing a targeted approach to treatment.
The gel is dispensed in a tube for easy and controlled application directly to the affected area. The recommended usage is twice a day for three consecutive days, followed by a four-day rest period. This cycle is typically repeated for up to 16 weeks or as directed by your healthcare provider.
It is important to note that Imiquimod 0.5% Vaginal Gel should not be used by pregnant women and should be used with caution in women who are breastfeeding. Always follow the instructions provided by your doctor or pharmacist when using this medication to ensure appropriate treatment.
Common side effects of Imiquimod 0.5% Vaginal Gel include burning, itching, redness, and swelling at the application site. If you experience any of these side effects, or if you have any questions or concerns about the medication, please do not hesitate to contact your doctor or pharmacist. Your health and well-being are our top priority.
If you have any further questions about Imiquimod 0.5% Vaginal Gel, please feel free to reach out to us at Bayview Pharmacy. We are here to assist you with your healthcare needs.
Imiquimod 0.5% Vaginal Gel is a specialized formulation designed for easy and controlled application in the vaginal area. This gel-like semisolid formulation is dispensed in a tube and is used for delivering medication or providing lubrication and therapeutic effects for various gynecological purposes. It has been used off-label for the treatment of conditions such as molluscum contagiosum, condyloma acuminata, and cutaneous T-cell lymphoma. Additionally, it has been utilized to treat external genital and perianal warts in pregnant women.
Imiquimod 0.5% Vaginal Gel has also been used in combination with other treatments such as cryotherapy, topical 5-fluorouracil, and photodynamic therapy for the treatment of actinic keratosis, Bowen's disease, and basal cell carcinoma. Furthermore, it has been employed to treat vulvar intraepithelial neoplasia. However, it is crucial to understand that the safety and efficacy of Imiquimod 0.5% Vaginal Gel for these off-label uses have not been established in clinical trials.
Patients considering this treatment should have a thorough discussion about the potential risks and benefits of using this formulation with their healthcare provider before starting treatment. If you have any questions about the use of Imiquimod 0.5% Vaginal Gel for any of these conditions, it is recommended to seek professional advice.
Imiquimod 0.5% Vaginal Gel is a gel-like semisolid formulation dispensed in a tube, specifically created for easy and controlled application in the vaginal area. It is used to deliver medication or provide lubrication and therapeutic effects for various gynecological purposes.
Imiquimod 0.5% Vaginal Gel is applied directly to the vaginal area. It is dispensed from a tube for easy and controlled application.
The gel is used to deliver medication, provide lubrication, and offer therapeutic effects for various gynecological purposes.
Yes, one of the purposes of Imiquimod 0.5% Vaginal Gel is to provide lubrication in the vaginal area.
The therapeutic effects of Imiquimod 0.5% Vaginal Gel vary depending on the individual's condition. It is primarily used for its medicinal properties in treating various gynecological conditions.
Yes, Imiquimod 0.5% Vaginal Gel is safe to use as directed by a healthcare professional. However, like all medications, it may have side effects and should be used under the supervision of a healthcare provider.
Imiquimod 0.5% Vaginal Gel is used for various gynecological purposes, but it may not be suitable for all conditions. It is important to consult with a healthcare provider to determine if this medication is appropriate for your specific needs.
The frequency of use for Imiquimod 0.5% Vaginal Gel depends on the specific condition being treated and the instructions provided by your healthcare provider. Always follow the directions given by your healthcare provider or pharmacist.
If you experience any side effects from using Imiquimod 0.5% Vaginal Gel, you should contact your healthcare provider immediately for advice.
Imiquimod 0.5% Vaginal Gel is a medication that requires a prescription from a healthcare provider. It is not available for purchase over the counter.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert/apply intravaginally
